Prescription Drug Pricing and Community Pharmacy NALEO Legislative Summit on Health October 21, 2017

Similar documents
Medicaid Prescription Drug Payment Reform

Covered Outpatient Drugs Federal Final Rule. Medical Assistance (MA) Program Fee-for-Service (FFS) Pharmacy Reimbursement

Understanding Pharmacy Benefit Management Services

December 15, 2017 (31 State SPAs)

M E D I C A I D P H A R M A C Y R E I M B U R S E M E N T S T A K E H O L D E R M E E T I N G

Value Choice. Summary of Benefits. January 1 December 31, 2014 S5660 & S5983. Y0046_B00SNS4B Accepted

Jill Rosenthal, MD, MA, MPH, FACOEM SVP, Chief Medical Officer Zenith Insurance Company

DIR fees are knocking down pharmacy profits

Medicare Modernization Act and Medicare Part D: Status of Implementation

State Bill Status Category Summary 4/11/ Referred to House of Representatives Ways and Means Committee

Overview of Coverage of Drugs Under the Medicaid Medical Benefit

DIR: Trends, Issues, and Impending Impacts

Percent of Employees Waiving Coverage 27.0% 30.6% 29.1% 23.4% 24.9%

Rural Policy Brief Volume 10, Number 8 (PB ) April 2006 RUPRI Center for Rural Health Policy Analysis

Presented January 20 th by Pharmacy Healthcare Solu7ons, Inc. Don Dietz, R.Ph, MS, Vice President

Establish fair elmbursements

Formulary Access for Patients with Mental Health Conditions

Specialty Pharmacy Trends: Payer and Industry Considerations for Specialty Pharmacies

TODAY S AGENDA. Opening Comments, Kevin B. Huber, CTPF executive director. Open Enrollment Overview. Enrollment and Eligibility

Implement a definition of negotiated price to include all pharmacy price concessions.

Medicare Part D in 2018: The Latest on Enrollment, Premiums, and Cost Sharing

Moving From PBM to PBA Model

SelectHealth Prescriptions

Pharmacy Program Management: Pitfalls, Challenges, and Best Practices About Solid Benefit Guidance specialty 60,000,000 covered member lives INSIDER

Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule

Pharmacy Benefit Strategies for Lowering Prescription Drug Costs

Glossary of Terms (Terms are listed in Alphabetical Order)

Today PBMs control the pharmacy benefits of more than 253 MILLION Americans.

Today PBMs control the pharmacy benefits of more than 253 MILLION. 3 PBMs. Americans.

THANK YOU SPONSORS 2

Archived 12.1 THE BASIS FOR ESTABLISHING A RATE OF PAYMENT DETERMINING A FEE... 2

RE: Mercer Professional Dispensing Fee and Actual Acquisition Cost Analysis for Medi- Cal-Pharmacy Survey Report

Pharmacy Acquisition Cost and Its Role in Contract Negotiating

Farm Bureau Select Rx 2017 Summary of Benefits January 1, December 31, 2017

Medicare Part D Prescription Drug Benefit For Agent Use Only

Pharmacy Benefit Strategies for Lowering. Prescription Drug Costs

In addition, MCHCP is requesting information about any programs or plans in place for non-medicare retirees.

Part D: The New Medicare Prescription Drug Law Implications for Medicaid

NCPA Summary of CMS Medicaid Covered Outpatient Drugs AMP Final Rule Prepared January NCPA Advocacy at Work

Pharmaceuticals: Can or Should We Do Anything About Rising Drug Costs? Caroline F. Pearson

Prescription Drug Plan Update

Farm Bureau Essential Rx 2018 Summary of Benefits January 1, December 31, 2018

Pharmacy Benefit Managers (PBMs)

2014 SUMMARY OF BENEFITS

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual Pricing & Reimbursement. Effective Date. March 2018

Impact of H.R. 1038/S. 413 on CMS Payments Under Part D

simple. secure. savings.

Proposed MAC Legislation May Increase Costs Of Affected Generic Drugs By More Than 50 Percent. Prepared for

Inside: Critical information about your company s prescription drug benefit.

State Pharmacy Assistance Programs: Additional Charts

The 2019 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

MEASURING THE IMPACT OF POINT OF SALE REBATES IN COLORADO S COMMERCIAL MARKET

Medicare Prescription Drug Congress. MMA and Medicaid. Gale Arden Director, Disabled & Elderly Health Programs Group CMSO CMS.

Prescription Drugs Spending Distribution and Cost Drivers. Steve Kappel January 25, 2007

Health Benefits Briefing

Aetna Medicare 2013 Benefits at a Glance

Follow the Dollar / Understanding Drug Prices and Beneficiary Costs Under Medicare Part D

The 2018 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

THE BIG 3 P s. Finding the Savings: Increasing Your Operational Efficiencies. Mark BonDurant Chief Consultant Independent Rx Consulting June 29, 2018

Pharmacy Stakeholder Meeting December 20, 2016

KEEPING PRESCRIPTION DRUGS AFFORDABLE: The Value of Pharmacy Benefit Managers (PBMs)

The Affordable Care Act (ACA)

National Council for Prescription Drug Programs

PHARMACY BENEFIT MANAGER (PBM)

YOUR TRUST PLAN BENEFITS

Prescription Drug Coverage

THIRD-PARTY PHARMACY RECONCILIATION

DIR FEES: WHAT YOU NEED TO KNOW JULY 13, :00 10:00 AM

How to Assist Beneficiaries Impacted by Aetna/Coventry 2015 Part D Plans

CLAIM FORM INSTRUCTIONS

INDUSTRY TRENDS IN PHARMACY REIMBURSEMENT

Pharmacy Benefits. Sarkis Kavarian, PharmD Candidate 2015 Preceptor Dr. Craig Stern Pro Pharma Pharmaceutical Consultants, Inc.

Survey of Community Pharmacies. Impact of Pharmacy Benefit Manager (PBM) Contracting and Auditing Practices on Patient Care.

Medicaid s Future. National PACE Association Spring Policy Forum. MaryBeth Musumeci

Proposed MAC Legislation May Increase Costs of Affected Generic Drugs By More Than 50 Percent. Prepared for

Exchange Market: 2015 National Snapshot

Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy

WorldatWork You and Your PBM: Improving Discounts, Fees and Rebates, and Beyond. Kristin Begley, Pharm.D. Principal

Making It Work: State Leadership on Medicare Rx Implementation and Coordinating with State Pharmacy Assistance Programs

ANALYSIS OF THE IMPACTS OF THE ACA S TAX ON HEALTH INSURANCE IN 2018 AND BEYOND - REVISED

Medicare Alert: Temporary Member Access

AETNA LIFE INSURANCE COMPANY

BERKELEY RESEARCH GROUP. Executive Summary

Medicare Part D Contract Analysis

Pharmacy Benefit Strategies for Lowering Prescription Drug Costs

What to Expect for Pharmacy Benefits and Drug Cost Trends for 2018 & 2019

Innovations: Using a Clinical Pharmacist as a Vehicle for Successful P4P Outcomes

Medicare Modernization Act (MMA)

How the Blueprint Policy Statement to Lower Drug Costs and Reduce Out-of- Pocket Costs May Affect Employers

How Does CCNC s Model Align with Value Based Payments? Lead Community Pharmacy Coordinator CCNC V.P. Moose Pharmacy Joe Moose, PharmD

Asuris Northwest Health Medicare Prescription Drug Plans (PDP)

Medicare Index Report: Annual Enrollment Period for 2019 Coverage

STATE OF THE LINE REPORT

2017 Plan Decision Guide Your guide to making an informed Medicare Part D choice

The Affordable Care Act and it s Impact on Employers

BENCHMARKING REPORT. Sponsored by PCCA

Medicare Congress: Fee for Service Trends: A Look at Medicare Part B

YOUR TRUST PLAN BENEFITS

Share a Clear View. El Paso Children's Hospital. Printed on:

Pharmacy services: payment for prescribed drugs.

Transcription:

Prescription Drug Pricing and Community Pharmacy NALEO Legislative Summit on Health October 21, 2017 Ronna Hauser, PharmD VP Pharmacy Affairs

The strength of our numbers NCPA represents America's 22,000+ independent community pharmacies. Together they represent an $80 billion health care marketplace and employ more than 250,000 people.

So how does this all work??!!

Prescription Reimbursement Methodologies Payers are using variations of the following: AWP (Average Wholesale Price) ASP (Average Sales Price) AMP (Average Manufacturers Price) WAC (Wholesale Acquisition Cost) MAC (Maximum Allowable Cost) AAC (Average Acquisition Cost) NADAC (National Average Drug Acquisition Cost)

Prescription Reimbursement Methodologies Community pharmacies most often paid for ingredient cost component based on % discount or markup on AWP or WAC for single-source drugs Purchaser defined MAC list for multiple source products Negotiated fee paid for professional services i.e. dispensing fee

Community Pharmacy Payment Methods Product based reimbursement formula expressed as follows: AWP-X% + $x.xx WAC+X% +$x.xx MAC+$x.xx (multiple-source drugs) Recent survey (2016) of employers showed average retail pharmacy brand drug reimbursement at AWP-18.63% + average dispensing fee of $1.42 Recent NCPA/NACDS COD study conducted by MPI found $10.55 to be national average Pharmacies are reimbursed differently based on the plan and the rates determined with the payer

Who Sets Patient Cost at Pharmacy Counter? Determined by the patient s coverage and PBM rules If the patient is on a copay type plan, their copay is independent of the total reimbursement to the pharmacy A Tier 3 brand drug with a $50 copay will be $50 to the member no matter which pharmacy the member utilizes as long as it is part of the payer s pharmacy network. If the member is on a coinsurance type plan, their coinsurance is determined by the reimbursement to the pharmacy A Tier 4 specialty drug with a 25% coinsurance would have a variable cost to the member as the 25% is usually calculated as 25% of the total cost of the prescription. The possibility of variability in member cost share exists in coinsurance based plans.

Who Sets Patient Cost at Pharmacy Counter? What Really Happens? Tiers are confusing Brand vs generic vs branded generic vs specialty etc. Prior authorization headache Preferred vs non preferred pharmacies Forced/incented mail order The lists of confusing policies goes on and on and on.

Snapshot: State Legislation on Drug Pricing CA: 60-day notice of price increases FL: State collects data on retail prices LA: Mfg. provides Board of Pharmacy current WAC info MD: Prohibits price gouging MA: Prohibits certain mfg. discounts NV: Requires mfg. and PBM to provide specific info NY: Est. Medicaid drug cap and detailed reporting VT: State annually identifies high spend drugs

For Community Pharmacy So What??? Independent community pharmacy is NEUTRAL on these approaches to date BUT we support efforts that address PBM practices that inflate drug costs at the counter Three large companies Express Scripts, CVSHealth and OptumRx cover more than 180 million lives, or roughly 78% of the market Non-transparent PBM business model can add hidden costs and lead to higher prices

PBM Impact on Drug Prices Since 1987, when Advance PCS/Caremark (now CVSHealth) became the last of the original "big 3" PBMs to incorporate, the others being Medco and Express Scripts which merged in 2012, total prescription drug expenditures have skyrocketed 1010% and per capita expenditures have increased 756%.

PBM Impact on Consumers Clawbacks Cost of the medication is lower than the patient's Copayment PBM instructs pharmacy to charge inflated Copay PBM "claws back" excess from pharmacy, keeping it Mail Order Pharmacy Choice DIR Fees Large Health Plans Deciding to Bring PBM Function In-House

NBC Nightly News With Lester Holt 10/17/17 2017/10/16 10:43 PM

Snapshot: Patient Fair Practices Legislation CT: Allows RPh to disclose cost of rx FL: Med synchronization must be offered benefit GA: Allows RPh to disclose cost of rx and deliver rx s HI: PBM s must register with insurance commissioner ME: PBM can t charge copayment exceeding cost of rx NH: Prohibits PBM requirements in excess of state board of pharmacy NC: Allows RPh to disclose cost of rx and deliver rx s and PBM can t charge copayment exceeding cost of rx TX: Requires PBMs register as delegated entities with insurance department

NCPA s Federal and State Legislative Priorities Direct and Indirect Remuneration (DIR) Fees S. 413 & H.R. 1038, The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act $3.4B savings over 10 years! Generic Drug Pricing Transparency H.R. 1316, The Prescription Drug Price Transparency Act Pharmacy Choice S. 1034/H.R. 1939, the Ensuring Seniors Access to Local Pharmacies Act Pharmacist Provider Status S. 109 / H.R. 592, The Pharmacy and Medically Underserved Areas Enhancement Act Patient Fair Practices

Ronna Hauser, PharmD VP, Pharmacy Affairs ronna.hauser@ncpanet.org (703) 838-2691